5ZFH
Mouse Kallikrein 7
Summary for 5ZFH
Entry DOI | 10.2210/pdb5zfh/pdb |
Descriptor | Kallikrein-7 (2 entities in total) |
Functional Keywords | protease, hydrolase |
Biological source | Mus musculus (Mouse) |
Total number of polymer chains | 1 |
Total formula weight | 24637.33 |
Authors | Sugawara, H. (deposition date: 2018-03-06, release date: 2018-06-27, Last modification date: 2024-10-16) |
Primary citation | Murafuji, H.,Sugawara, H.,Goto, M.,Oyama, Y.,Sakai, H.,Imajo, S.,Tomoo, T.,Muto, T. Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-ones. Bioorg. Med. Chem., 26:3639-3653, 2018 Cited by PubMed Abstract: A series of 1,3,6-trisubstituted 1,4-diazepan-7-ones were prepared as kallikrein 7 (KLK7, stratum corneum chymotryptic enzyme) inhibitors. Previously reported compounds 1-3 were potent human KLK7 inhibitors; however, they did not exhibit inhibitory activity against mouse KLK7. Comparison of the human and mouse KLK7 structures reveals the cause of this species differences; therefore, compounds that could inhibit both KLK7s were designed, synthesized, and evaluated. Through this structure-based drug design, compound 22g was identified as an inhibitor against human and mouse KLK7, and only one of the enantiomers, (-)-22g, exhibited potent inhibitory activity. Furthermore, the crystal structure of mouse KLK7 complexed with 22g enabled the elucidation of structure-activity relationships and justified 22g as a valuable compound to overcome the species differences. PubMed: 29884582DOI: 10.1016/j.bmc.2018.05.044 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.93 Å) |
Structure validation
Download full validation report
